Cloud-clone
SKU:SEB975Hu
ELISA Kit for Tenascin C (TNC)
ELISA Kit for Tenascin C (TNC)
Couldn't load pickup availability
Enzyme-linked immunosorbent assay for Antigen Detection.
Product No.
SEB975Hu
Organism Species
Homo sapiens (Human).
Sample Type
serum, plasma, tissue homogenates and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3h
Detection Range
3.12-200ng/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 1.25ng/mL.
UOM
48T 96T 96T*5 96T*10 96T*100
Specificity
This assay has high sensitivity and excellent specificity for detection of Tenascin C (TNC).
No significant cross-reactivity or interference between Tenascin C (TNC) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Tenascin C (TNC) and the recovery rates were calculated by comparing the measured value to the expected amount of Tenascin C (TNC) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 86-98 | 94 |
| EDTA plasma(n=5) | 80-102 | 86 |
| heparin plasma(n=5) | 96-103 | 99 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Tenascin C (TNC) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Tenascin C (TNC) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Tenascin C (TNC) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 94-101% | 83-102% | 88-95% | 90-102% |
| EDTA plasma(n=5) | 87-103% | 95-103% | 92-99% | 93-102% |
| heparin plasma(n=5) | 82-93% | 94-103% | 89-103% | 78-90% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
| Standard | 2 | Standard Diluent | 1×20mL |
| Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
| Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
| TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
| Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
| Magazine | Citations |
| Medical Principles and Practice | An investigation of tenascin-C levels in rheumatic mitral stenosis and their response to percutaneous mitral balloon valvuloplasty Pubmed: 22889719 |
| Tumor Biology | Clinical significance of serum tenascin-c levels in epithelial ovarian cancer Springer: Source |
| Tumor Biology | Clinical significance of serum tenascin-C levels in breast cancer Springer: Source |
| BioFactors | Tenascin-C is increased in atherothrombotic stroke patients and has an anti-inflammatory effect in the human carotid artery. Pubmed:24823872 |
| Connective Tissue Research | Metabolic and cytoprotective effects of in vivo peri-patellar hyaluronic acid injections in cultured tenocytes Pubmed:25333747 |
| K | Role of Tenascin-C in the differential diagnosis of small round blue cell tumors Index.Php: Sdutfd |
| Life Sci | A new predictor of mortality in hemodialysis patients; Tenascin-C PubMed: 26390818 |
| Heart Research | Biomarkers Score for Patients with Mitral Stenosis: A useful conjunction with Wilkins’s Score for Early Intervention Heartresearchopenjournal: Hroj5 |
| Araştırmalar / Researches | Pankreas Adenokarsinomunda Serum Tenascin-C Düzeyi Potansiyel Bir Biyobelirteç Midir? Cpdf:5C21620161255 |
| Archives of Dermatological Research | Increased tenascin C and DKK1 in vitiligo: possible role of fibroblasts in acral and non-acral disease Pubmed:29605863 |
| Methods in Cell Biology | How to detect and purify tenascin-C Pubmed:29310788 |
| Scientific Reports | Altered transcriptional regulatory proteins in glioblastoma and YBX1 as a potential regulator of tumor invasion Pubmed: 31358880 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPB975Hu02 | Recombinant Tenascin C (TNC) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB975Hu01 | Recombinant Tenascin C (TNC) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB975Hu01 | Polyclonal Antibody to Tenascin C (TNC) | WB; IHC; ICC; IP. |
| LAB975Hu71 | Biotin-Linked Polyclonal Antibody to Tenascin C (TNC) | WB; IHC; ICC. |
| MAB975Hu22 | Monoclonal Antibody to Tenascin C (TNC) | WB; IHC; ICC; IP. |
| MAB975Hu21 | Monoclonal Antibody to Tenascin C (TNC) | WB; IHC; ICC; IP. |
| MAB975Hu23 | Monoclonal Antibody to Tenascin C (TNC) | WB; IHC; ICC; IP. |
| MAB975Hu24 | Monoclonal Antibody to Tenascin C (TNC) | WB; IHC; ICC; IP. |
| SEB975Hu | ELISA Kit for Tenascin C (TNC) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB975Hu | Magnetic Luminex Assay Kit for Tenascin C (TNC) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
